Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria
2018 · Blood Cancer Journal · 273 citations
https://doi.org/10.1038/s41408-018-0077-4
M
Moritz Binder
WinnMed(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
430
Papers
2.8K
Citations
28
h-index
65
i10-index
Moritz Binder is an academic researcher from WinnMed. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Cancer Mechanisms and Therapy & Peptidase Inhibition and Analysis. The author has an h-index of 28, co-authored 366 publications.
ORCID: 0000-0001-9014-9658Papers by this author
worksRAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis
2021 · Nature Communications · 95 citations
https://doi.org/10.1038/s41467-021-23186-w
Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
2017 · Blood Cancer Journal · 85 citations
https://doi.org/10.1038/bcj.2017.83
Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia
2020 · Blood Cancer Journal · 35 citations
https://doi.org/10.1038/s41408-020-00387-y
Common Genetic Variation in CYP17A1 and Response to Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer
2016 · International Journal of Molecular Sciences · 23 citations
https://doi.org/10.3390/ijms17071097
Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab
2022 · Leukemia · 20 citations
https://doi.org/10.1038/s41375-021-01501-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat